PTC Therapeutics Inc.

PTCT | NASDAQ

Price Alert Chart Builder DCF Calculator

$65.26

-$0.11 (-0.17%)

At close: Sep 21, 2026, 4:00 PM ET

$65.99

+$0.73 (+1.12%)

Pre-market: Sep 22, 2026, 6:45 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ALKS Alkermes plc	N/A
ARWR Arrowhead Pharmaceuticals	N/A
KRYS Krystal Biotech	N/A
PCVX Vaxcyte	N/A
PTGX Protagonist Therapeutics	N/A
RNA Atrium Therapeutics	N/A
TGTX TG Therapeutics	N/A

Dividend Rankings ➞

Recent News

6 days ago / seekingalpha.com
PTC Therapeutics, Inc. (PTCT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
7 days ago / defenseworld.net
California State Teachers Retirement System Has $543.82 Million Stock Position in PTC Therapeutics, Inc. $PTCT
1 month ago / seekingalpha.com
PTC Therapeutics, Inc. (PTCT) Discusses Acquisition of ST-920 Fabry Gene Therapy Asset and Clinical Data from STAAR Study Transcript
2 months ago / zacks.com
PTC Therapeutics (PTCT) Loses 20.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2 months ago / zacks.com
PTC Therapeutics (PTCT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
2 months ago / seekingalpha.com
PTC Therapeutics, Inc. (PTCT) Q2 2026 Earnings Call Transcript
2 months ago / zacks.com
PTC Therapeutics (PTCT) Beats Q2 Earnings and Revenue Estimates
3 months ago / zacks.com
PTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should Know
3 months ago / zacks.com
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?
3 months ago / gurufocus.com
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes